Awards Nomination 20+ Million Readerbase
PMC/PubMed Indexed Articles

Maintenance and Intensification of Bivalent Oral Poliovirus Vaccine Use Prior to its Coordinated Global Cessation

MEFA (multiepitope fusion antigen)-Novel Technology for Structural Vaccinology, Proof from Computational and Empirical Immunogenicity Characterization of an Enterotoxigenic Escherichia coli (ETEC) Adhesin MEFA

View More »

Google Scholar citation report
Citations : 2327

Journal of Vaccines & Vaccination received 2327 citations as per Google Scholar report

Journal of Vaccines & Vaccination
Journal of Vaccines & Vaccination peer review process verified at publons
Flyer image
Indexed In
  • Academic Journals Database
  • Open J Gate
  • Genamics JournalSeek
  • JournalTOCs
  • China National Knowledge Infrastructure (CNKI)
  • Scimago
  • Ulrich's Periodicals Directory
  • RefSeek
  • Hamdard University
  • EBSCO A-Z
  • OCLC- WorldCat
  • Publons
  • MIAR
  • University Grants Commission
  • Geneva Foundation for Medical Education and Research
  • Euro Pub
  • Google Scholar
View More
Useful Links
Share This Page
Open Access Journals
View More

Pin Chen

Pin Chen

National Key Laboratory of Agricultural Microbiology, Huazhong Agricultural University, Wuhan, Hubei, 430070, China

Biography
Dr. Ping Chen, Ph.D. Co-Founder of PharmaResources (Shanghai) Co., Ltd. and serves as its Chairman and Chief Executive Officer. Dr. Chen has over 17 years of experience in Medicinal Chemistry at Bristol-Myers Squibb. He is a primary inventor on Dasatinib (SprycelTM), a marketed drug targeting BCR-ABL/Src kinases for the treatment of Chronic Myelogenous Leukemia (CML) and Philadelphia chromosome-positive Acute Lymphoblastic Leukemia (ALL).